SBC Medical Group SBC
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 87th percentile, 5-year average 13.1x
#1135 of 2992 stocks by PE (1 = cheapest)
Near the top of its 5-year range · 92nd percentile, 5-year average 1.1x
#3556 of 5329 stocks by PB (1 = cheapest)
Near the top of its 5-year range · 99th percentile, 5-year average 1.3x
#3759 of 5156 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 2.64 | – | 1.14 | 92% (pricier than usual) | #3556 of 5329 (1 = cheapest) |
| PE | 14.41 | 14.08 | 13.12 | 87% (pricier than usual) | #1135 of 2992 (1 = cheapest) |
| PS | 4.32 | 3.57 | 1.25 | 99% (pricier than usual) | #3759 of 5156 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on SBC.
Sign in to join the discussion.